Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair (Q37724579)

22 August 2017

1 reference

title

Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair (English)

1 reference

22 August 2017

1 reference

mesenchymal stem cell

1 reference

6

Peishun Shou

1 reference

22 August 2017

Yufang Shi

1

1 reference

22 August 2017

Gangzheng Hu

2

1 reference

22 August 2017

Juanjuan Su

3

1 reference

22 August 2017

Wenzhao Li

4

1 reference

22 August 2017

Qing Chen

5

1 reference

22 August 2017

Chunliang Xu

7

1 reference

22 August 2017

Xiaodong Chen

8

1 reference

22 August 2017

Yin Huang

9

1 reference

22 August 2017

Zhexin Zhu

10

1 reference

22 August 2017

Xin Huang

11

1 reference

22 August 2017

Xiaoyan Han

12

1 reference

22 August 2017

Ningxia Xie

13

1 reference

22 August 2017

Guangwen Ren

14

1 reference

22 August 2017

6 April 2010

1 reference

22 August 2017

1 reference

22 August 2017

20

1 reference

22 August 2017

510-518

1 reference

22 August 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1038/cr.2010.44

22 August 2017

0 references

cites work

Mesenchymal stem cells: revisiting history, concepts, and assays.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Multilineage potential of adult human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Pluripotency of mesenchymal stem cells derived from adult marrow

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

A dermal niche for multipotent adult skin-derived precursor cells.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Adult bone marrow stromal cells differentiate into neural cells in vitro

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Stem cell regeneration of degenerated intervertebral discs: current status

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Systemic transplantation of human adipose stem cells attenuated cerebral inflammation and degeneration in a hemorrhagic stroke model.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Subretinal transplantation of bone marrow mesenchymal stem cells delays retinal degeneration in the RCS rat model of retinal degeneration.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

A Phase I Clinical Trial of the Treatment of Crohn's Fistula by Adipose Mesenchymal Stem Cell Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Technology insight: adult mesenchymal stem cells for osteoarthritis therapy

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cell homing: the devil is in the details

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mechanisms involved in the therapeutic properties of mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Efficient colonic mucosal wound repair requires Trem2 signaling

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Alternative activation of macrophages

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

The immune system and cardiac repair.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Immunosuppression by placental indoleamine 2,3-dioxygenase: a role for mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Human mesenchymal stem cells modulate B-cell functions

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Interactions between human mesenchymal stem cells and natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Human mesenchymal stem cells modulate allogeneic immune cell responses

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Chemotaxis of human articular chondrocytes and mesenchymal stem cells.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells in health and disease

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells: properties and role in clinical bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells in arthritic diseases

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Engraftment potential of human placenta-derived mesenchymal stem cells after in utero transplantation in rats

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Mesenchymal stem cells use integrin beta1 not CXC chemokine receptor 4 for myocardial migration and engraftment

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

The Wnt modulator sFRP2 enhances mesenchymal stem cell engraftment, granulation tissue formation and myocardial repair.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Targeted delivery of progenitor cells for cartilage repair.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2010.44

7 January 2021

Identifiers

DOI

10.1038/CR.2010.44

1 reference

release_ggixpa6p5zci3ore3x3pslpxku

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ggixpa6p5zci3ore3x3pslpxku

24 November 2022

mapped directly with Wikidata item

1 reference